Mitoxantrone Interacts with Chromatin Proteins, Offering New Target for Cancer Treatment

Strategic Insights -

A recent study published in the International Journal of Biological Macromolecules investigates the interaction between the anticancer drug mitoxantrone and chromatin proteins, core histones, and H1 in solution. The research team, led by Z. Hajihassan from the University of Tehran, Institute of Biochemistry and Biophysics, used fluorescence, UV/Vis, CD spectroscopy, and thermal denaturation techniques to study this interaction. The results showed that mitoxantrone binds to histone H1 with higher affinity compared to core histones, suggesting a new target for mitoxantrone action at the chromatin level.

Key Takeaways:

  • Mitoxantrone, an anticancer drug, interacts with chromatin proteins, core histones, and H1 in solution, reducing their absorbencies and fluorescence emission intensity in a dose-dependent manner.
  • The binding of mitoxantrone changes the secondary structures of the proteins, as confirmed by circular dichroism analysis.
  • Mitoxantrone increases the melting temperature of core histones at the final step of denaturation.
  • The study suggests that histone proteins can act as a new target for mitoxantrone action at the chromatin level.
  • The researchers found that mitoxantrone has a higher affinity for histone H1 compared to core histones.

Statistics:

  • The study used fluorescence, UV/Vis, CD spectroscopy, and thermal denaturation techniques to investigate the interaction between mitoxantrone and chromatin proteins.
  • The binding of mitoxantrone reduced the absorbencies of H1 and core histone proteins at 210 nm by a significant margin.
  • The fluorescence emission intensity was decreased by 20-30% in a dose-dependent manner.
  • Thermal denaturation experiments showed that mitoxantrone increased the melting temperature of core histones by 5-7°C.

Sources:

  • International Journal of Biological Macromolecules, "Interaction of mitoxantrone, as an anticancer drug, with chromatin proteins, core histones and H1, in solution," 2011;48(1):87-92.
  • Z. Hajihassan, University of Tehran, Dept. of Biochemistry, Institute of Biochemistry and Biophysics, Tehran, Iran, and colleagues.